JP TSE 4553 Pharmaceutical

TOWA Pharmaceutical Co., Ltd.

東和薬品株式会社

Revenue

¥274B

≈ $1.7B

Net income

¥5.2B

≈ $33.2M

Income taxes paid

¥8.5B

≈ $54.0M

Total assets

¥475B

≈ $3.0B

Equity ratio

37.5%

Ranked #485 among listed Japanese companies by corporate taxes paid · effective tax rate 60.1%.

Share price at fiscal year-end: ¥4,005 · market capitalization ¥206B · P/E 37.5 · P/B 1.16

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥274B	¥5.2B	¥7.9B	¥8.5B	¥475B	¥178B	37.5%	EDINET (consol.)
Mar 2025	¥260B	¥19.0B	¥7.3B	¥10.9B	¥471B	¥172B	36.5%	EDINET (consol.)
Mar 2024	¥228B	¥16.2B	—	—	¥431B	¥156B	36.2%	EDINET (consol.)
Mar 2023	¥209B	¥2.2B	—	—	¥371B	¥137B	36.9%	EDINET (consol.)
Mar 2022	¥166B	¥15.9B	—	—	¥332B	¥132B	39.8%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.